Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2; no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedUpdated the Publications section to note that PubMed publications are automatically filled and may not relate to the study, and updated the revision label from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a new 'Last Update Posted (Estimated)' timestamp and recent date markers (2025-11-07, 2025-11-06, 2025-11); a government funding notice was removed.SummaryDifference0.7%

- Check43 days agoChange DetectedOnly minor UI adjustments and an updated last-modified timestamp are visible; core study details, eligibility criteria, and primary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdate: version from v3.0.2 to v3.1.0, indicating a new release.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.